ArticleClinical cancer research : an official journal of the American Association for Cancer Research2011

Inhibition of prostate cancer osteoblastic progression with VEGF121/rGel, a single agent targeting osteoblasts, osteoclasts, and tumor neovasculature.

Khalid A Mohamedali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.